Tolvaptan on Hemodynamic Parameters in Pts. w/ Heart Failure

ID Number 04-1331

Principal Investigator(s)
Sean P Pinney

Department(s) or Division(s)

Research Entity
The Zena and Michael A. Wiener Cardiovascular Institute


This study will look at how a single dose of study medication (tolvaptan) versus an inactive sugar pill (placebo) effect pressures in the heart in patients with congestive heart failure. Higher than normal pressures can be related to symptoms of heart failure (shortness of breath, fatigue, etc.). Identifier: NCT00132886

Contact Information
Sean Pinney
(212) 241-7300 

Recruiting Patients: No